Sure. So thanks for the question, Ygal. Maybe I'll start. Yeah, I mean, so what we saw in Q1 was really improvements in demand levels from January into February and March. And as I said in the prepared remarks, an overall continuation of that positive trend of the improving growth rates for the legacy Teads business into Q2, so far so good. We haven't seen any meaningful impact in our results to date stemming from, you know, the uncertainty in the macro. You know, clarifying maybe what I said on the call, you know, the shortened selling and buying cycles, you know, maybe, as an example, if you, you know, typically, might get, you know, a month or two months warning on a budget, maybe it comes in, you know, a few weeks closer to the start date than typical. So, you know, to us, that indicates, obviously, there's more scrutinization of the ad spend happening, which obviously, you know, the second part of your question, we view as a good thing for us. But, you know, obviously, there is a little bit of, you know, visibility, and obviously, I think, you know, you have to factor that into your giving the outlook and the guidance. You know, obviously, verticals, you know, we look at, you know, there's, you know, some stronger, some weaker, but nothing unusual, I would say. And, you know, as I said, we're seeing really more positives than negatives at this point, you know, in terms of, you know, the legacy Outbrain business continues growth in the same growth drivers, yields are up, the improvement, as I said, in the year-over-year growth rates for legacy Teads in the U.S. in particular, which is encouraging. You know, positivity that we see in the team is eagerly starting the early days here of the cross-sell. We have our first wins there. So generally good things. Obviously, we're being balanced in our guidance just given the uncertainty, but, you know, so far so good is how I would view it.